Quotient was founded by Flagship Pioneering in 2022, in collaboration with world-renowned academic co-founders. Our accomplished and experienced leadership team is backed by experts in the field of somatic genetics to deliver on the promise of our platform.

President & CEO

Growth Partner, Flagship Pioneering

Former EVP Biopharmaceuticals R&D, AstraZeneca

Board Director, Quotient and Origination Partner, Flagship Pioneering

Senior Group Leader, Sanger Institute

Board Director, Quotient, and General Partner, Flagship Pioneering